SciBase's Nevisense Secures Payer Coverage in US with Highmark Blue Cross Blue Shield

05:25 AM EDT, 10/14/2026 (MT Newswires) -- SciBase Holding's (SCIB.ST) Nevisense secured its first positive medical policy from Highmark Blue Cross Blue Shield in the US, broadening its reach across dermatology practices and patients in the country. The decision allows the use of the dermatology-focused medical technology company's medical device to move to covered care through a private insurer from a cash-pay model, according to a Wednesday release. SciBase said the coverage gives it the opportunity to expand its reach in the US market.